BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35005878)

  • 1. Positron emission tomography-magnetic resonance imaging as a research tool in musculoskeletal conditions.
    van den Wyngaert T; de Schepper S; Elvas F; Seyedinia SS; Beheshti M
    Q J Nucl Med Mol Imaging; 2022 Mar; 66(1):15-30. PubMed ID: 35005878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/Computed Tomography Scans and PET/MR Imaging in the Diagnosis and Management of Musculoskeletal Diseases.
    Manhas NS; Salehi S; Joyce P; Guermazi A; Ahmadzadehfar H; Gholamrezanezhad A
    PET Clin; 2020 Oct; 15(4):535-545. PubMed ID: 32888549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of PET-Computed Tomography-Magnetic Resonance in the Management of Benign Musculoskeletal Disorders.
    Yoder JS; Kogan F; Gold GE
    PET Clin; 2019 Jan; 14(1):1-15. PubMed ID: 30420212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging with PET-CT and PET-MRI in Pediatric Musculoskeletal Diseases.
    Guja KE; Behr G; Bedmutha A; Kuhn M; Nadel HR; Pandit-Taskar N
    Semin Nucl Med; 2024 May; 54(3):438-455. PubMed ID: 38688770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future Perspective of the Application of Positron Emission Tomography-Computed Tomography-MR Imaging in Musculoskeletal Disorders.
    Angelini A; Castellucci P; Ceci F
    PET Clin; 2019 Jan; 14(1):183-191. PubMed ID: 30420219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging.
    Gholamrezanezhad A; Basques K; Batouli A; Matcuk G; Alavi A; Jadvar H
    AJR Am J Roentgenol; 2018 Jun; 210(6):W245-W263. PubMed ID: 29787313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
    Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
    Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of positron emission tomography/magnetic resonance imaging in musculoskeletal malignancies.
    García Cañamaque L; Field CA; Furtado FS; Plaza DE Las Heras I; Husseini JS; Balza R; Jarraya M; Catalano OA; Mitjavila Casanovas M
    Q J Nucl Med Mol Imaging; 2022 Mar; 66(1):3-14. PubMed ID: 34881853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Molecular Imaging of Musculoskeletal Inflammation and Infection.
    Pawaskar A; Basu S; Jahangiri P; Alavi A
    PET Clin; 2019 Jan; 14(1):43-59. PubMed ID: 30420221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/MR Imaging in Musculoskeletal Precision Imaging - Third wave after X-Ray and MR.
    Hancin EC; Borja AJ; Nikpanah M; Raynor WY; Haldar D; Werner TJ; Morris MA; Saboury B; Alavi A; Gholamrezanezhad A
    PET Clin; 2020 Oct; 15(4):521-534. PubMed ID: 32768369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography/magnetic resonance: Present and future].
    Kohan AA; Vercher Conejero JL; Gaeta MC; Pelegrí Martinez L; Ros PR
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):167-76. PubMed ID: 23582491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive advantage of PET/MRI.
    Jadvar H; Colletti PM
    Eur J Radiol; 2014 Jan; 83(1):84-94. PubMed ID: 23791129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/MR Imaging in Musculoskeletal Disorders.
    Andersen KF; Jensen KE; Loft A
    PET Clin; 2016 Oct; 11(4):453-63. PubMed ID: 27593249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Applications of PET/CT/MR Imaging in Inflammatory Diseases: Part I: Musculoskeletal and Gastrointestinal Systems.
    Katal S; Gholamrezanezhad A; Nikpanah M; Christensen TQ; Werner TJ; Saboury B; Alavi A; Hess S
    PET Clin; 2020 Oct; 15(4):547-558. PubMed ID: 32768367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancies between positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography in a cohort of oncological patients.
    Oh G; O'Mahoney E; Jeavons S; Law P; Ngai S; McGill G; Yu C; Miles KA
    J Med Imaging Radiat Oncol; 2020 Apr; 64(2):204-210. PubMed ID: 32037655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.
    Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/Computed Tomography and PET/MR Imaging: Basic Principles, Methodology, and Imaging Protocol for Musculoskeletal Applications.
    Parghane RV; Basu S
    PET Clin; 2018 Oct; 13(4):459-476. PubMed ID: 30219182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid PET-MRI Applications in Movement Disorders.
    Tondo G; Esposito M; Dervenoulas G; Wilson H; Politis M; Pagano G
    Int Rev Neurobiol; 2019; 144():211-257. PubMed ID: 30638455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.